Download Free Platinum Blues Book in PDF and EPUB Free Download. You can read online Platinum Blues and write the review.

Like most supplement volumes of the platinum-group metal series,Platinum Suppl. Vol. A 1 has been written by an international team of specialists. It comprises technological data of all six platinum-group metals and their technically relevant alloys and compounds. The volume starts with a review on the recovery of the platinum-group metals (23 pages); the next 42 pages are devoted to processes for separating and refining the PGM in order to obtain metals of high purity. The electrodeposition of the PGM and their alloys is treated on 26 pages.The by far most extensive section deals with PGMand their alloys and compounds in catalysis. After a historicalsurvey and alist of important reviewson PGMcatalysis,the catalytic properties of the metals are treated in a general way, followed by unsupported metals and alloys including preparation of catalysts and their reactions in various industrial processes. The role of supported metals and alloys is described in asimilar manner. This isfollowed byan extensive description of the preparation and the reactions of PGM compounds with various nonmetals and their catalytically active role in a number of industrial processes (226 pages). The last chapter (21 pages) is a compilation of data on the medical use of cytostatic platinum compounds. Gelnhausen, December 1985 Kurt Swars IX Table of Contents Page Technology ofthe Platinum-Group Metals. ............................... 1 1 Review on the Recovery ofthe Platinum-Group Metals . 1.1 Historical Perspective , , , . Period of Discovery, 1750 to 1820 , , . First Industrial Period 1820 to 1900 , , , .
Provides historical perspective as well as current data Abundantly illustrated with figures redrawn from literature data Covers all pertinent theory and physical chemistry Catalytic and chemotherapeutic applications are included
This unique book bridges the gap between undergraduate and research-level electrochemistry books, as an introduction to electrochemical applications within inorganic chemistry.
Proceedings of the Fifth International Symposium, held in Abano Terme (Padova), italy, June 29-July 2, 1987
In this “fast-paced, wickedly funny” legal thriller, a small-town lawyer’s case against a Los Angeles record label turns into a deadly media circus (Publishers Weekly). Living in the Northern California town of Foolsgold, widowed lawyer Oliver Gulliver is headed for a midlife crisis. It doesn’t help that his eighteen-year-old daughter Elora has fallen in love with alcoholic former rock star C.C. Gilley. But then C.C. quits drinking and gets to work on a comeback album. Things actually seem to be looking up—until C.C.’s car is stolen, with his priceless demo tape inside. In no time at all, another band is all over the radio with C.C.’s song, and Oliver finds himself in Los Angeles working the biggest case of his life—suing a billion-dollar record company for plagiarism. But even as Oliver discovers his talent for charming the public, he finds out how nasty the music industry can get. When the stakes skyrocket from plagiarism to murder, Oliver will have to try C.C.’s case like his life depends on it—because it does. “Reeling off witty turns of phrase and uncanny plot twists, Deverell offers wonderfully sardonic takes on the worlds of music, law, Hollywood, Southern California and fatherhood--just for starters.” —Publishers Weekly
Specialist Periodical Reports provide systematic and detailed review coverage of progress in the major areas of chemical research. Written by experts in their specialist fields the series creates a unique service for the active research chemist, supplying regular critical in-depth accounts of progress in particular areas of chemistry. For over 80 years the Royal Society of Chemistry and its predecessor, the Chemical Society, have been publishing reports charting developments in chemistry, which originally took the form of Annual Reports. However, by 1967 the whole spectrum of chemistry could no longer be contained within one volume and the series Specialist Periodical Reports was born. The Annual Reports themselves still existed but were divided into two, and subsequently three, volumes covering Inorganic, Organic and Physical Chemistry. For more general coverage of the highlights in chemistry they remain a 'must'. Since that time the SPR series has altered according to the fluctuating degree of activity in various fields of chemistry. Some titles have remained unchanged, while others have altered their emphasis along with their titles; some have been combined under a new name whereas others have had to be discontinued. The current list of Specialist Periodical Reports can be seen on the inside flap of this volume.
30 years after its discovery as an antitumor agent, cisplatin represents today one of the most successful drugs in chemotherapy. This book is intended to reminisce this event, to take inventory, and to point out new lines of development in this field. Divided in 6 sections and 22 chapters, the book provides an up-to-date account on topics such as - the chemistry and biochemistry of cisplatin, - the clinical status of Pt anticancer drugs, - the impact of cisplatin on inorganic and coordination chemistry, - new developments in drug design, testing and delivery. It also includes a chapter describing the historical development of the discovery of cisplatin. The ultimate question - How does cisplatin kill a cell? - is yet to be answered, but there are now new links suggesting how Pt binding to DNA may trigger a cascade of cellular reactions that eventually result in apoptosis. p53 and a series of damage recognition proteins of the HMG-domain family appear to be involved. The book addresses the problem of mutagenicity of Pt drugs and raises the question of the possible relevance of the minor DNA adducts, e.g. of interstrand cross-links, and the possible use of trans-(NH3)2Pt(II)-modified oligonucleotides in antisense and antigene strategies. Our present understanding of reactions of cisplatin with DNA is based upon numerous model studies (from isolated model nucleobases to short DNA fragments) and application of a large body of spectroscopic and other physico-chemical techniques. Thanks to these efforts there is presently no other metal ion whose reactions with nucleic acids are better understood than Pt. In a series of chapters, basic studies on the interactions of Pt electrophiles with nucleobases, oligonucleotides, DNA, amino acids, peptides and proteins are reported, which use, among others, sophisticated NMR techniques or X-ray crystallography, to get remarkable understanding of details on such reactions. Reactivity of cisplatin, once bound to DNA and formerly believed to be inert enough to stay, is an emerging phenomenon. It has (not yet) widely been studied but is potentially extremely important. Medicinal bioinorganic chemistry - the role of metal compounds in medicine - has received an enormous boost from cisplatin, and so has bioinorganic chemistry as a whole. There is hardly a better example than cisplatin to demonstrate what bioinorganic chemistry is all about: The marriage between classic inorganic (coordination) chemistry and the other life sciences - medicine, pharmacy, biology, biochemistry. Cisplatin has left its mark also on areas that are generally considered largely inorganic. The subject of mixed-valance Pt compounds is an example: From the sleeping beauty it made its way to the headlines of scientific journals, thanks to a class of novel Pt antitumor agents, the so-called "platinum pyrimidine blues". In the aftermath diplatinum (III) compounds were recognized and studies in large numbers, and now an organometalic chemistry of these diplatinum (III) species is beginning to emerge. The final section of the book is concerned with new developments such as novel di- and trinuclear Pt(II) drugs with DNA binding properties different from those of cisplatin, with orally active Pt(IV) drugs which are presently in clinical studies, and with attempts to modify combinatorial chemistry in such a way that it may become applicable to fast screening of Pt antitumor drugs. The potential of including computational methods in solving questions of Pt-DNA interactions is critically dealt with in the concluding chapter.